ABOUT THIS PODCAST
ASHP’s education director, Hannah Post, is joined by Kristin Zimmerman, associate professor at Virginia Commonwealth University Health, as she discusses her upcoming Midyear session that focuses on GLP-1 receptor agonist effects on substance use and addictive behaviors in both clinical trials and the real-world population.
SPEAKERS
- Kristin Zimmerman, PharmD, BCGP, FCCP
Associate Professor
Virginia Commonwealth University School of Pharmacy - Hannah Post, PharmD, BCPS
Education Director, National Meetings Education
ASHP





